The Pharmacy Times® Asthma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the treatment of the chronic lung disease, in which the airways narrow and swell.
May 5th 2024
With these findings contributing to the understanding of neighborhood-level asthma risks, the authors note next steps can involve identifying and addressing disparities.
Study: Asthma, Hay Fever, Other Allergies Not Linked to Mental Health Traits
October 29th 2021Evidence of a causal relationship between the onset of allergic disease and mental health was limited, suggesting that the observational associations found were due to confounding or other forms of bias.
Read More
FDA Approves Dupilumab for Children Aged 6 to 11 With Moderate to Severe Asthma
October 21st 2021The approval is based on data from a phase 3 placebo-controlled trial that evaluated the efficacy and safety of dupilumab combined with standard-of-care therapy in children with uncontrolled moderate-to-severe asthma.
Read More
Study Identifies Non-Th2 Asthma as Unique Disease, Demonstrates Air Pollutant as Likely Contributor
April 21st 2021This is the first study to demonstrate air pollution as a driver of the most challenging type of asthma to treat, the severe non-Th2 subtype, which is non-responsive to current therapies.
Read More